• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Spectral AI Inc.

    11/14/24 4:09:49 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care
    Get the next $MDAI alert in real time by email
    SC 13G/A 1 d796843dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    Spectral AI, Inc.

    (Name of Issuer)

    Common stock, par value $0.0001 per share

    (Title of Class of Securities)

    84757T105

    (CUSIP Number)

    September 30, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 84757T105

     

     1.   

     Names of Reporting Persons.

     I.R.S. Identification Nos. of above persons (entities only).

     

     Octopus Investments Limited

     2.  

     Check the Appropriate Box if a Member of a Group (See Instructions)

     (a) ☐  (b) ☐

     

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     United Kingdom

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

       5.   

     Sole Voting Power

     

     0

       6.  

     Shared Voting Power

     

     0

       7.  

     Sole Dispositive Power

     

     0

       8.  

     Shared Dispositive Power

     

     0

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     ☐

    11.  

     Percent of Class Represented by Amount in Row (9)

     

     0

    12.  

     Type of Reporting Person (See Instructions)

     

    HC, CO


    This Amendment No. 1 to Statement on Schedule 13G (the “Amendment”) is being filed by Octopus Investments Limited (the “Reporting Person”) that amends, supplements and supersedes the initial Statement on Schedule 13G filed by the Reporting Person with the U.S. Securities and Exchange Commission on February 8, 2024 (the “Schedule 13G”). This Amendment is the final amendment to the Schedule 13G and constitutes an exit filing for the Reporting Person. 

    Item 1.

    (a) Name of Issuer:

    Spectral AI, Inc.

    (b) Address of Issuer’s Principal Executive Offices:

    2515 McKinney Avenue

    Suite 1000

    Dallas, TX 75201

    Item 2.

    (a) Name of Person Filing:

    Octopus Investments Limited

    (b) Address of Principal Business Office or, if none, Residence:

    6th Floor, 33 Holborn, London, EC1N 2HT

    (c) Citizenship:

    United Kingdom

    (d) Title of Class of Securities:

    Common Stock, $0.0001 par value per share.

    (e) CUSIP Number:

    84757T105

     

    Item 3.

    If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:

    Not applicable

     

    Item 4.

    Ownership

    (a) Amount beneficially owned:

    The information required by Item 4(a) is set forth in Row 9 of the cover page for the Reporting Person and is incorporated herein by reference.


    (b) Percent of class:

    The information required by Item 4(b) is set forth in Row 11 of the cover page for the Reporting Person and is incorporated herein by reference.

    (c) Number of shares as to which the person has:

    The information required by Item 4(c) is set forth in Rows 5-8 of the cover page for the Reporting Person and is incorporated herein by reference.

    This filing is the final amendment to the Schedule 13G and constitutes an exit filing for the Reporting Person.

     

    Item 5.

    Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person

    Not applicable

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

    Not Applicable

     

    Item 8.

    Identification and Classification of Members of the Group

    Not applicable

     

    Item 9.

    Notice of Dissolution of Group

    Not applicable

     

    Item 10.

    Certifications

    Not applicable


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: November 14, 2024

     

    Octopus Investments Limited
    By:  

    /s/ John Averill

      Name: John Averill
      Title: CRO
    Get the next $MDAI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MDAI

    DatePrice TargetRatingAnalyst
    1/23/2024$4.00Buy
    BTIG Research
    More analyst ratings

    $MDAI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Dimaio John Michael bought $10,320 worth of shares (6,000 units at $1.72), increasing direct ownership by 0.40% to 2,491,908 units (SEC Form 4)

    4 - Spectral AI, Inc. (0001833498) (Issuer)

    5/14/24 11:17:43 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    $MDAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dimaio John Michael was granted 44,000 shares, increasing direct ownership by 2% to 2,731,847 units (SEC Form 4)

    4 - Spectral AI, Inc. (0001833498) (Issuer)

    6/29/26 4:01:19 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Director Dimaio John Michael was granted 17,500 shares, increasing direct ownership by 0.66% to 2,687,847 units (SEC Form 4)

    4 - Spectral AI, Inc. (0001833498) (Issuer)

    6/1/26 4:00:40 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Director Dimaio John Michael was granted 32,233 shares, increasing direct ownership by 1% to 2,670,347 units (SEC Form 4)

    4 - Spectral AI, Inc. (0001833498) (Issuer)

    5/27/26 5:16:36 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    $MDAI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on Spectral AI with a new price target

    BTIG Research initiated coverage of Spectral AI with a rating of Buy and set a new price target of $4.00

    1/23/24 7:24:00 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    $MDAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication

    DALLAS, July 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of Darcy Bajko as Chief Commercial Officer, effective July 31, 2026. Ms. Bajko will lead the commercial functions in support of Spectral AI’s global launch of its DeepView® System for burn indication, which was granted De Novo Classification by the U.S. Food and Drug Administration (FDA) in May 2026. "Darcy’s appointment further strengthens our executive team and represents an important step for Spectral AI as we pivot

    7/8/26 8:30:00 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    DeepView® System Highlighted at the 2026 British Burn Association Annual Conference

    DALLAS, June 25, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today reflected on its successful participation at the British Burn Association (BBA) Annual Conference, held on June 17th – 19th  at the Nottingham Trent University, Nottingham, England.    The Company’s DeepView® System was on display and was the subject of multiple podium and poster presentations during the conference, highlighting its contributions to advancing burn care through advanced diagnostic analysis across the globe. The presentation fr

    6/25/26 8:30:00 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

    DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, is joining the American Board of Wound Management (ABWM) Foundation in celebrating the 10th Annual Wound Healing Awareness Month. In this milestone year, during the month of June the ABWM Foundation will continue its mission of raising awareness, empowering certified wound care specialists, and transforming lives. "Wound Healing Awareness Month is an important reminder that patients living with painful, sometimes complex burn wounds require a timely

    6/12/26 8:30:00 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    $MDAI
    SEC Filings

    View All

    Spectral AI Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Spectral AI, Inc. (0001833498) (Filer)

    7/8/26 4:01:28 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Spectral AI Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Spectral AI, Inc. (0001833498) (Filer)

    6/1/26 4:01:42 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Spectral AI Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Spectral AI, Inc. (0001833498) (Filer)

    5/26/26 4:00:52 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    $MDAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Spectral AI Inc.

    SC 13G/A - Spectral AI, Inc. (0001833498) (Subject)

    11/14/24 4:09:49 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Spectral AI Inc. (Amendment)

    SC 13G/A - Spectral AI, Inc. (0001833498) (Subject)

    4/19/24 6:49:51 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Spectral AI Inc. (Amendment)

    SC 13D/A - Spectral AI, Inc. (0001833498) (Subject)

    2/27/24 2:07:28 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    $MDAI
    Financials

    Live finance-specific insights

    View All

    Spectral AI Announces 2026 First Quarter Financial Results

    Development Work for DeepView® Systems Continues with Support of Recently Awarded $31.7 Million of Funding from BARDA Reiterates Annual Revenues Guidance DALLAS, May 12, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the first quarter ended March 31, 2026. "Our results for the 2026 first quarter reflected the progress we have made in developing our DeepView® System for burn indication under the base phase of our Project BioShield Contract with BARDA," said Vincent Capone, Chief

    5/12/26 4:10:00 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call

    DALLAS, April 28, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the first quarter ended March 31, 2026 on Tuesday, May 12, 2026 after the close of the Nasdaq stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time on the same day to discuss its financial results. Investors interested in participating in the live call can dial into the conference call as follows: 833-890-6620 – U.S.412-564-3789 – International In addit

    4/28/26 4:15:00 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026

    Overview Full Year Research & Development Revenue of $19.7 Million; Q4 2025 Revenue of $3.8 MillionCash Rose to $15.4 Million at December 31, 2025 DALLAS, March 24, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence ("AI") company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the fourth quarter ("Q4 2025") and full year ("FY 2025") ended December 31, 2025 and provided an update on its ongoing activities related to the commercialization of its proprietary, AI-driven DeepView® System for burn indication. "2025 was a pivotal year fo

    3/24/26 4:25:00 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    $MDAI
    Leadership Updates

    Live Leadership Updates

    View All

    Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication

    DALLAS, July 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of Darcy Bajko as Chief Commercial Officer, effective July 31, 2026. Ms. Bajko will lead the commercial functions in support of Spectral AI’s global launch of its DeepView® System for burn indication, which was granted De Novo Classification by the U.S. Food and Drug Administration (FDA) in May 2026. "Darcy’s appointment further strengthens our executive team and represents an important step for Spectral AI as we pivot

    7/8/26 8:30:00 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Spectral AI Announces Voting Results of Annual Meeting of Stockholders

    DALLAS, June 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced results from its 2026 Annual Meeting of Stockholders, held on May 29, 2026. The Company also provided an overview of its accomplishments to date and targeted milestones for 2026 following the receipt of De Novo Classification for its DeepView® System from the U.S. Food and Drug Administration ("FDA"). 2026 Annual Meeting of Stockholders A total of 17,267,570 shares representing 54.3% of the Company's total shares outstanding were re

    6/1/26 8:00:00 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Spectral AI Names David McGuire, CPA, as Chief Financial Officer

    DALLAS, April 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of David McGuire as the Company's Chief Financial Officer, effective May 4, 2026. "David's appointment as CFO is another important step in strengthening Spectral AI's financial leadership and strategic readiness as we prepare for commercialization of the DeepView® System," said Vincent S. Capone, Spectral AI's Chief Executive Officer. "David is a seasoned public company executive with experience in global markets, fin

    4/8/26 8:30:00 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care